Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
about
In vitro culture medium influences the vaccine efficacy of Mycobacterium bovis BCGAn Update on Global Tuberculosis (TB)A point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strainsMyBASE: a database for genome polymorphism and gene function studies of MycobacteriumSignificant under expression of the DosR regulon in M. tuberculosis complex lineage 6 in sputum.Identification of genes and genomic islands correlated with high pathogenicity in Streptococcus suis using whole genome tiling microarrays.Probing genomic diversity and evolution of Streptococcus suis serotype 2 by NimbleGen tiling arrays.Origins of a 350-kilobase genomic duplication in Mycobacterium tuberculosis and its impact on virulenceGenomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection.Region of difference 2 contributes to virulence of Mycobacterium tuberculosis.Genome sequencing and analysis of BCG vaccine strains.Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway.Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection.Whole-genome sequences of four Mycobacterium bovis BCG vaccine strainsGenome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis.Adaptation to environmental stimuli within the host: two-component signal transduction systems of Mycobacterium tuberculosis.Lipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 substrain.Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.Commonly administered bacille Calmette-Guerin strains induce comparable immune response.Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms.BCG vaccine in Korea.Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine.A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens.BCG immunotherapy for bladder cancer--the effects of substrain differences.Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting MemoryComparative genomics of mycobacteria: some answers, yet more new questions.Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strA DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice.Evolution and Strain Variation in BCG.Attenuated Bacterial Vaccines
P2860
Q24599551-E0892EB4-4FDB-454A-B6D4-6445E70E3FE4Q26996438-8AFC9D41-E572-49B8-9053-4019970D28A9Q28482347-76077FA1-625A-4849-9C6E-A90A192B6960Q33410707-978AE907-0B51-45F9-8F1C-16DC7C2BCEE5Q33647642-C3A36126-719E-45DF-8748-C4F100F5A3EAQ33867385-A7E94ED0-B195-45C3-9E86-9AF9D28E2286Q33893386-133B2798-7949-4653-A8C1-F727BA437C82Q33899774-7B992FBD-A78D-4747-9512-B373CBD43EE3Q34043904-ACF73902-EB1F-4CBF-8177-296345334FA0Q34484770-DFAB3DF9-DBD1-4C7C-841B-04EF33F21754Q34970721-A8C27957-3CD3-4D62-BBC9-A48045990A52Q34998258-0A3497BB-72C0-4BA3-8F93-ACBC557EB85DQ35075851-7B85B0AA-BB00-464A-9086-2D445E5C12FDQ35096242-C024F171-79B5-475F-BEA7-DB6B5D128397Q35274553-72596B48-843B-4234-819F-FCC63765A3D1Q35598334-2BE5B68A-9EBA-4AA4-99DB-DC71A4BEE45AQ35626170-ED85E187-CD0D-4AB8-AE0C-3F40A90788A2Q36187495-1C7E8451-07CB-4D93-A455-E78A5D139003Q36317705-1E388704-E5CB-466D-B482-FEF61D003321Q36756892-21574AFA-7192-4BF5-A783-BCDCDB7AAAD1Q37011018-CC51D379-FBCA-4084-986E-4637DF0E77D8Q37054583-3ABC3B31-998F-43B4-A0F1-2643412EF221Q37704762-EA713926-864B-4D8B-8C62-05CDFD97B16FQ38138412-429B9F3B-0165-4D87-99A9-03DC6AAED773Q38207991-E7AAF0AF-187E-408E-B28F-E3D50ECE44AEQ38268060-3F8B03C6-5642-40CA-9C73-B1B59C29F775Q38385719-F0E7BA08-5D1C-4849-B7A8-7ACFF6DA0F25Q39994755-86A01449-B7DC-452E-9C63-BC76CAD4A75DQ44053607-AF332A05-123C-49FE-8865-C5D3F76ED38FQ47223264-BA06CFA8-5DF7-4609-8A0D-260949B1811FQ57915185-9BEF7CC6-8D09-4472-BC4C-6AC84E97AFF3
P2860
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@ast
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@en
type
label
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@ast
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@en
prefLabel
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@ast
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@en
P2093
P2860
P50
P356
P1433
P1476
Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.
@en
P2093
Andrea S Leung
David C Alexander
P2860
P2888
P356
10.1186/1471-2164-9-413
P407
P577
2008-09-15T00:00:00Z
P5875
P6179
1024190782